213 related articles for article (PubMed ID: 35776676)
21. Sonographic features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma and intraductal cholangiocarcinoma.
Kim NR; Kim SH; Lee JM; Lee KH; Kim YJ; An SK; Jung AY; Han JK; Choi BI
J Ultrasound Med; 2004 Oct; 23(10):1283-91. PubMed ID: 15448317
[TBL] [Abstract][Full Text] [Related]
22. Molecular classification of hepatocellular adenoma in clinical practice.
Nault JC; Paradis V; Cherqui D; Vilgrain V; Zucman-Rossi J
J Hepatol; 2017 Nov; 67(5):1074-1083. PubMed ID: 28733222
[TBL] [Abstract][Full Text] [Related]
23. MRI appearance of combined hepatocellular cholangiocarcinoma.
Billet N; Grégory J; Ronot M
Diagn Interv Imaging; 2022 Dec; 103(12):625-626. PubMed ID: 36243674
[No Abstract] [Full Text] [Related]
24. Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging.
Huang B; Wu L; Lu XY; Xu F; Liu CF; Shen WF; Jia NY; Cheng HY; Yang YF; Shen F
Radiology; 2016 Oct; 281(1):150-7. PubMed ID: 27077381
[TBL] [Abstract][Full Text] [Related]
25. Cancer stem cells in primary liver cancers: pathological concepts and imaging findings.
Joo I; Kim H; Lee JM
Korean J Radiol; 2015; 16(1):50-68. PubMed ID: 25598674
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
[TBL] [Abstract][Full Text] [Related]
27. Contrast-Enhanced Ultrasound for Differentiation Between Poorly Differentiated Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Guo HL; Zheng X; Cheng MQ; Zeng D; Huang H; Xie XY; Lu MD; Kuang M; Wang W; Xian MF; Chen LD
J Ultrasound Med; 2022 May; 41(5):1213-1225. PubMed ID: 34423864
[TBL] [Abstract][Full Text] [Related]
28. Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.
Kang HJ; Kim H; Lee DH; Hur BY; Hwang YJ; Suh KS; Han JK
Radiology; 2021 Sep; 300(3):572-582. PubMed ID: 34227881
[TBL] [Abstract][Full Text] [Related]
29. β-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study.
Ando S; Shibahara J; Hayashi A; Fukayama M
Virchows Arch; 2015 Nov; 467(5):535-42. PubMed ID: 26311355
[TBL] [Abstract][Full Text] [Related]
30. Diversity in cell differentiation, histology, phenotype and vasculature of mass-forming intrahepatic cholangiocarcinomas.
Nguyen Canh H; Takahashi K; Yamamura M; Li Z; Sato Y; Yoshimura K; Kozaka K; Tanaka M; Nakanuma Y; Harada K
Histopathology; 2021 Nov; 79(5):731-750. PubMed ID: 34018212
[TBL] [Abstract][Full Text] [Related]
31. Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake.
Lee JD; Yang WI; Park YN; Kim KS; Choi JS; Yun M; Ko D; Kim TS; Cho AE; Kim HM; Han KH; Im SS; Ahn YH; Choi CW; Park JH
J Nucl Med; 2005 Oct; 46(10):1753-9. PubMed ID: 16204727
[TBL] [Abstract][Full Text] [Related]
32. Clinical and ultrasonographic findings in four cows with liver tumours.
Braun U; Nuss K; Soldati G; Ossent P
Vet Rec; 2005 Oct; 157(16):482-4. PubMed ID: 16227385
[No Abstract] [Full Text] [Related]
33. Variant Hepatocellular Carcinoma Subtypes According to the 2019 WHO Classification: An Imaging-Focused Review.
Loy LM; Low HM; Choi JY; Rhee H; Wong CF; Tan CH
AJR Am J Roentgenol; 2022 Aug; 219(2):212-223. PubMed ID: 35170359
[TBL] [Abstract][Full Text] [Related]
34. Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.
Choi SY; Kim YK; Min JH; Kang TW; Jeong WK; Ahn S; Won H
Eur Radiol; 2018 Jun; 28(6):2549-2560. PubMed ID: 29335868
[TBL] [Abstract][Full Text] [Related]
35. Detection of combined hepatocellular and cholangiocarcinomas on enhanced CT: comparison with histologic findings.
Nishie A; Yoshimitsu K; Asayama Y; Irie H; Aibe H; Tajima T; Shinozaki K; Nakayama T; Kakihara D; Shimada M; Aishima S; Yoshida K; Honda H
AJR Am J Roentgenol; 2005 Apr; 184(4):1157-62. PubMed ID: 15788587
[TBL] [Abstract][Full Text] [Related]
36. A case of mucinous cholangiocarcinoma showing features of hepatocellular carcinoma.
Kai K; Ide Y; Miyoshi A; Masuda M; Ide T; Kitahara K; Irie H; Nakajima J; Noshiro H; Tokunaga O
Pathol Int; 2013 Aug; 63(8):419-21. PubMed ID: 23957918
[No Abstract] [Full Text] [Related]
37. Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management.
Shanbhogue AK; Prasad SR; Takahashi N; Vikram R; Sahani DV
Radiology; 2011 Mar; 258(3):673-93. PubMed ID: 21339346
[TBL] [Abstract][Full Text] [Related]
38. Different MR features for differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma according to tumor size.
Ni T; Shang XS; Wang WT; Hu XX; Zeng MS; Rao SX
Br J Radiol; 2018 Jul; 91(1088):20180017. PubMed ID: 29791202
[TBL] [Abstract][Full Text] [Related]
39. Combined hepatocellular carcinoma and cholangiocarcinoma: a case report and review of the literature.
Zhou YM; Yang JM; Wang B; Xu F; Tong Y; Li DQ
Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):656-9. PubMed ID: 18086637
[TBL] [Abstract][Full Text] [Related]
40. Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.
Somorácz A; Tátrai P; Horváth G; Kiss A; Kupcsulik P; Kovalszky I; Schaff Z
Hum Pathol; 2010 Sep; 41(9):1310-9. PubMed ID: 20471664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
